Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine versus placebo in outpatients with major depressive disorder and painful physical symptoms
2004-003742-18Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Cymbalta with Placebo (2 arms). Primary endpoint: Change in BPI-SF average pain score from baseline over 8 weeks. Started Mar 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2004-003742-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003742-18.